SGH, page-99

First 99 Last

Share
Profile

Follow
croasian

2,251 Posts.

54

20/04/18

06:01

Post #: 32573572
Share

Originally posted by Dr.Who ↑

Jim, Mr Grech said at the 2015 AGM briefing that debt/equity ratio at 43% was above their preferred level and will get it down to 30% through converting WIP (worded to the effect of not going to look for verbatim quote)

S&P index rebalances happen every quarter. March, June, Sept, Dec - at April 2015 SGH was on the verge of admitted to ASX100. It wasn't in the inde until the rebalance In June 2015.

As you say I should have known that, it looks like I did!

Also thought it would be interesting to recap some broker (who were covering the company) quotes from that time April 2015.

What do the brokers think?

UBS has taken a positive stance on the new look Slater and Gordon with analyst Jack Briggs noting the group will become the largest player in the UK personal injury market with a share of 12 per cent and enjoy the added benefits of first-time access to the insurers and insurance brokers customer acquisition channel.

Briggs also said, “There is a high degree of conservatism in Slater and Gordon’s EBITDA estimates as no synergies have been assumed, and case assumptions also look conservative relative to current levels".

UBS upgraded its recommendation from neutral to buy and increased the 12 month price target from $7.45 to $8.83.

Deutsche Bank was also upbeat about the development, but Dominic Rose noted the relatively high transaction multiple. However, she echoed UBS’s comments in saying, “Upside potential exists from improving the business and extracting synergies".

Rose has a buy recommendation on the stock with a 12 month price target of $8.20, but this is likely to be reviewed once the deal has closed.

Morningstar is one of the more bullish in terms of assessing Slater and Gordon’s robust position within deregulated and highly fragmented markets, and this is reflected in its fair value estimate of $10.00.

Expand

Pretty useless analysts why did you listen to them? Why dredge them up now, was your bad decision.

As Einstein said (referring to the military):
He who joyfully marches to music rank and file, has already earned my contempt. He has been given a large brain by mistake, since for him the spinal cord would surely suffice.

Success in investing can't happen to those who march to the beat of some-one else's drum.

SGH Price at posting: $3.10 Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

There are more pages in this discussion • 268 more messages in this thread...

First 99 Last

Add SGH (ASX) to my watchlist

SGH, page-99

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News